ASP Isotopes (NASDAQ:ASPI) Trading Down 8% – Time to Sell?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price fell 8% on Monday . The company traded as low as $5.85 and last traded at $5.8350. 6,307,505 shares were traded during mid-day trading, a decline of 7% from the average session volume of 6,752,706 shares. The stock had previously closed at $6.34.

Analyst Upgrades and Downgrades

ASPI has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Cantor Fitzgerald assumed coverage on ASP Isotopes in a research note on Thursday, December 4th. They set an “overweight” rating and a $13.00 target price for the company. Canaccord Genuity Group restated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a report on Monday, November 24th. Finally, Loop Capital set a $15.00 price objective on ASP Isotopes in a research note on Monday, October 27th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Stock Down 4.9%

The stock has a 50 day moving average price of $6.47 and a 200 day moving average price of $8.43. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The company has a market capitalization of $668.37 million, a P/E ratio of -4.64 and a beta of 3.47.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The company had revenue of $4.89 million for the quarter, compared to analysts’ expectations of $2.25 million. Equities research analysts forecast that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Activity

In other news, Chairman Paul Elliot Mann sold 162,153 shares of the stock in a transaction on Monday, December 1st. The stock was sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the transaction, the chairman owned 7,759,538 shares in the company, valued at approximately $44,617,343.50. This represents a 2.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Heather Kiessling sold 80,000 shares of ASP Isotopes stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $5.80, for a total transaction of $464,000.00. Following the completion of the transaction, the chief financial officer owned 732,500 shares of the company’s stock, valued at $4,248,500. The trade was a 9.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 505,591 shares of company stock valued at $3,233,245 in the last 90 days. Insiders own 14.40% of the company’s stock.

Hedge Funds Weigh In On ASP Isotopes

Several hedge funds have recently bought and sold shares of ASPI. Quantbot Technologies LP purchased a new position in shares of ASP Isotopes during the 3rd quarter valued at $34,000. Ameritas Investment Partners Inc. raised its holdings in shares of ASP Isotopes by 41.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after buying an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. Pictet Asset Management Holding SA bought a new stake in shares of ASP Isotopes in the 4th quarter worth approximately $61,000. Finally, Close Asset Management Ltd bought a new stake in ASP Isotopes in the third quarter worth $72,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.